MedPlus to take full control of Optival in ₹1.10 crore deal
NiveshIQ
NSE: MEDPLUS · Healthcare
Medplus Health Services Ltd.
₹660.15▲ ₹2.10 (+0.32%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on MEDPLUS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Medplus Health Services Ltd.
MedPlus Health Services Limited is a leading Indian healthcare company that engages in the retail trading of medicines and general items, with a diverse product portfolio including pharmaceuticals, wellness items, medical devices, and fast-moving consumer goods. The company's core business is driven by its retail and online channels, with a strong presence in India. Key revenue drivers for MedPlus include its pharmacy business, wholesale cash and carry operations, and diagnostic services, which contributed to revenues of ₹7229 Cr in the latest financial year. Recently, the company's subsidiary faced drug license suspensions, and there has been an increase in pledged shares to 17.27% of the total equity. Despite these challenges, MedPlus has been expanding its operations, with investments o
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹5,624 Cr +23.40% | ₹6,136 Cr +9.10% | ₹6,892 Cr +12.30% |
| EBITDA Margin | 6.29% | 8.73% | 9.85% |
| Net Profit | ₹67.00 Cr +34.00% | ₹150.23 Cr +124.20% | ₹219.61 Cr +46.20% |
| EPS | ₹5.48 | ₹12.56 | ₹18.33 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
MedPlus to take full control of Optival in ₹1.10 crore deal
MedPlus Board Addresses SEBI Compliance Fine Over Director Appointment
🔒
+ 3 more stories about Medplus Health Services Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹1, 880 Cr, PAT ₹33 Cr, EPS ₹2.76, EBITDA margin 8.1%. Growth context: revenue QoQ +0.8%, PAT QoQ -48.2%. Street verdict: strong beat, revenue surprise +1.8%, PAT surprise +41.6%.
Key growth drivers for MEDPLUS are poised to emanate from product launches, regulatory approvals, and an improving thera...
MEDPLUS's FY26 performance was marked by revenue of ₹6, 892 Cr, PAT of ₹220 Cr, an EBITDA margin of 9.8%, and EPS of ₹18...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for MEDPLUS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track MEDPLUS alongside your other holdings
Unlock full MEDPLUS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Medplus Health Services Ltd.?
NiveshIQ detects active intelligence signals for Medplus Health Services Ltd. (MEDPLUS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Medplus Health Services Ltd.?
Medplus Health Services Ltd. operates in the Healthcare sector with a market capitalisation of ₹1,069,964.5L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.